Timothy J.Heverin (Tim)

Of Counsel

Chicago + 1.312.269.4087

For 20 years Tim Heverin has represented clients in high-value patent and trade secret disputes, often involving international actors, activity, and witnesses. In doing so he has appeared before district courts across the country, the Federal Circuit, the International Trade Commission (ITC), and the Patent Trial and Appeal Board (PTAB).

In particular, Tim has extensive experience litigating life science patent disputes. He has represented clients in matters concerning pharmaceutical and biologic products such as Prezista®, Hytrin®, Tricor®, Istodax®, and Kuvan®. He recently was part of the team that successfully defeated an institution of four inter partes reviews (IPRs) and defended a separate interference action related to formulation patents for the top-selling drug Humira®.

In addition to his pharmaceutical work, Tim has handled patent disputes relating to medical devices, chemical processing, semiconductor fabrication and function, microchip architecture, information theory and coding, and search and database mining.

Prior to attending law school, Tim worked in the U.S. Naval Nuclear Propulsion Program as a nuclear plant engineer at Knolls Atomic Power Laboratory's Kesselring site, where, among other things, he instructed Naval officers in nuclear plant operation and casualty response.


  • Freescale defends against patent infringement action related to methods of wireless data transmissionJones Day defended Freescale Semiconductor, Inc. in a patent suit alleging infringement of five patents relating to interfaces for serially transmitting or receiving data, acquiring a GPS signal using data bit information, detecting jamming signals in wireless communication devices, and testing responses of radio transceivers.
  • Celgene files declaratory judgment action against CyclacelJones Day represents plaintiff Celgene Corporation in a declaratory judgment action for non-infringement and invalidity of four Cyclacel Pharmaceuticals, Inc. patents related to certain depsipeptides and uses thereof.
  • Abbott prevails in patent infringement action against SandozJones Day represented Abbott Laboratories ("Abbott") in a patent infringement action brought under the Hatch-Waxman Act in the United States District Court for the District of Delaware against Sandoz, Inc.
  • Freescale and Interphase defend against patent infringement allegations over semiconductor technologyJones Day defended Freescale Semiconductor, Inc. and Interphase Corporation against allegations of infringing eight patents relating to various aspects of semiconductor technology.
  • IBM defends against patent infringement charges relating to data management on computer networksJones Day represented defendant IBM in a patent infringement case relating to management of data caching on computer networks.
  • Additional Speaking Engagements

    • January 2012
      Jones Day Chicago hosts University of Illinois BLSA students in an informational panel